Skip to main content
Equibles

Brittany Bradrick

Board Member

Dermata Therapeutics, Inc. (DRMA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Dermata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get DRMA alerts

About Brittany Bradrick

Brittany Bradrick is recorded as Board Member at Dermata Therapeutics, Inc. (DRMA) since May 27, 2026. Dermata Therapeutics, Inc. reported in an 8-K filed May 27, 2026 that Brittany Bradrick was appointed Class II director. Dermata Therapeutics, Inc. reported in an 8-K filed August 3, 2023 that Brittany Bradrick was appointed Class II director, effective August 3, 2023. Dermata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dermata Therapeutics, Inc. includes Gerald T. Proehl (CEO and Board Member), Kyri K. Van Hoose (CFO), Kyri Van Hoose (CFO) and 7 others.

“The stockholders elected David Hale, Steven Mento, Ph.D. and Brittany Bradrick as Class II directors to serve until the 2029 annual meeting and until their successors have been duly elected and qualified.”
Dermata Therapeutics, Inc. Form 8-K, filed May 27, 2026 · Read the filing
“The election of David Hale, Steven Mento, and Brittany Bradrick as Class II directors to hold office for a term of three years, until their successor is duly elected and qualified or they are otherwise unable to complete their term.”
Dermata Therapeutics, Inc. Form 8-K, filed August 3, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Dermata Therapeutics, Inc.

Recent activity